Keyphrases
Heart Failure Patients
100%
Acute Decompensated Heart Failure
100%
Inotropic Therapy
100%
Levosimendan
100%
Milrinone
100%
B-type Natriuretic Peptide
36%
Quality of Life
18%
Echocardiography
18%
Heart Failure
18%
Maximal O2 Consumption
18%
Placebo
9%
Absence of Evidence
9%
Quality of Life Improvement
9%
Quality of Life Questionnaire
9%
Heart Failure Hospitalization
9%
Outpatient Clinic
9%
Left Ventricular Ejection Fraction
9%
New York Heart Association Class
9%
Two-point
9%
Definitive Treatment
9%
Single-center Study
9%
Test Failure
9%
Cardiopulmonary Exercise Testing
9%
Once-weekly
9%
4-cycle
9%
Heart Failure Clinic
9%
Annular Velocity
9%
Guideline-directed Medical Therapy
9%
Ambulatory Heart Failure
9%
Right Ventricular Systolic Function
9%
EQ-5D-5L Questionnaire
9%
Medicine and Dentistry
Heart Failure
100%
Inotropism
100%
Milrinone
100%
Levosimendan
100%
Quality of Life
36%
Natriuretic Factor
36%
Echocardiography
18%
Oxygen Consumption
18%
Outpatient
9%
Placebo
9%
Combination Therapy
9%
Systolic Function
9%
Heart Left Ventricle Ejection Fraction
9%
Cardiopulmonary Exercise Test
9%
New York Heart Association Class
9%